Intelligent Investor

Immuron Limited (ASX: IMC) - Announcements

Current share price for IMC : $0.105 0.005 (5%)

ASX company news and announcements for Immuron Limited (IMC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immuron Limited (IMC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immuron Limited (IMC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immuron Limited (IMC)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$24 Immuron CEO Steven Lydeamore to present at The Watchlist 23 Apr 2024 9:17AM $0.100 $0.105 $0.100 risen by 5%
$24 Immuron to host Live Virtual Event 15 Apr 2024 10:34AM $0.105 $0.105 $0.100 fallen by 0%
$24 Immuron Travelan sales continued strong growth 10 Apr 2024 9:00AM $0.110 $0.105 $0.100 fallen by 4.55%
$24 Change in substantial holding 22 Mar 2024 8:24AM $0.099 $0.105 $0.100 risen by 6.06%
$24 Notice under section 708A 14 Mar 2024 10:53AM $0.110 $0.105 $0.100 fallen by 4.55%
$24 Change of Director's Interest Notice (DP) 14 Mar 2024 10:45AM $0.110 $0.105 $0.100 fallen by 4.55%
$24 Application for quotation of securities - IMC 14 Mar 2024 10:40AM $0.110 $0.105 $0.100 fallen by 4.55%
$24 Immuron CEO, Steven Lydeamore to present at Coffee Microcaps 14 Mar 2024 8:25AM $0.110 $0.105 $0.100 fallen by 4.55%
$24 Change in substantial holding 14 Mar 2024 8:20AM $0.110 $0.105 $0.100 fallen by 4.55%
$24 Travelan to progress to Phase 3 Clinical Trials in the US 7 Mar 2024 10:03AM $0.066 $0.105 $0.100 risen by 59.09%
$24 Trading Halt 5 Mar 2024 9:28AM $0.066 $0.105 $0.100 risen by 59.09%
$24 Change in substantial holding 1 Mar 2024 8:22AM $0.072 $0.105 $0.100 risen by 45.83%
$24 Appendix 4D and Half Year Report 28 Feb 2024 1:25PM $0.070 $0.105 $0.100 risen by 50%
$24 Presentation to Australian Biologics Festival 2024 21 Feb 2024 8:36AM $0.073 $0.105 $0.100 risen by 43.84%
$24 Immuron achieves record Travelan sales 13 Feb 2024 9:43AM $0.076 $0.105 $0.100 risen by 38.16%
$24 Investor Webinar Presentation 8 Feb 2024 9:26AM $0.073 $0.105 $0.100 risen by 43.84%
$24 Immuron achieves record half yearly Travelan sales 16 Jan 2024 9:26AM $0.076 $0.105 $0.100 risen by 38.16%
$24 Immuron Clinical Trials Update 22 Dec 2023 3:24PM $0.079 $0.105 $0.100 risen by 32.91%
$24 First Patients Enrolled in Campylobacter Clinical Study 4 Dec 2023 4:27PM $0.081 $0.105 $0.100 risen by 29.63%
$24 Investor Webinar Presentation 28 Nov 2023 4:13PM $0.084 $0.105 $0.100 risen by 25%
$24 Change of Director's Interest Notice (PB) 24 Nov 2023 1:55PM $0.076 $0.105 $0.100 risen by 38.16%
$24 Notification regarding unquoted securities - IMC 24 Nov 2023 1:46PM $0.076 $0.105 $0.100 risen by 38.16%
$24 Amended Constitution 22 Nov 2023 5:41PM $0.080 $0.105 $0.100 risen by 31.25%
$24 Results of Annual General Meeting 21 Nov 2023 12:15PM $0.080 $0.105 $0.100 risen by 31.25%
$24 Presentation to Annual General Meeting 21 Nov 2023 8:30AM $0.078 $0.105 $0.100 risen by 34.62%

1 - 25 of 608 results

Page 1 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.